, Vaincre la Mucoviscidose et Institut national d'études démographiques (Ined), 2013.
Cystic fibrosis: insight into CFTR pathophysiology and pharmacotherapy, Clin Biochem, vol.45, issue.15, pp.1132-1176, 2012. ,
DOI : 10.1016/j.clinbiochem.2012.05.034
Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis, Am J Respir Crit Care Med, vol.190, issue.10, pp.1111-1127, 2014. ,
DOI : 10.1164/rccm.201407-1277oc
URL : https://api.research-repository.uwa.edu.au/files/5127783/Ramsey_2014_CF_longitudinal_spirometry_AJRCCM_R1_clean_FINAL.pdf
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis, J Infect Dis, vol.183, issue.3, pp.444-52, 2001. ,
Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?, J Antimicrob Chemother, vol.65, issue.11, pp.2373-75, 2010. ,
DOI : 10.1093/jac/dkq342
URL : https://academic.oup.com/jac/article-pdf/65/11/2373/2304109/dkq342.pdf
Microbial ecology and adaptation in cystic fibrosis airways, Environ Microbiol, vol.13, issue.7, pp.1682-89, 2011. ,
Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes, Am J Respir Crit Care Med, vol.190, issue.3, pp.289-97, 2014. ,
Epidémiologie bactérienne des patients atteints de mucoviscidose suivis au Centre de Ressources et de Compétences de la Mucoviscidose de nancy en 1997 et en, vol.1, 2007. ,
, Conférence de consensus : Prise en charge du patient atteint de mucoviscidose, Rev Mal Respir, vol.20, pp.149-57, 2003.
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus, Eur Respir J, vol.16, issue.4, pp.749-67, 2000. ,
Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis, J Pediatr, vol.138, issue.5, pp.699-704, 2001. ,
DOI : 10.1067/mpd.2001.112897
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis, Pediatr Pulmonol, vol.34, issue.2, pp.91-100, 2002. ,
Eradication therapy for Pseudomonas aeruginosa colonization episodes in cystic fibrosis patients not chronically colonized by P. aeruginosa, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.12, issue.1, pp.1-8, 2013. ,
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis, Cochrane Database of Systematic Reviews, 2014. ,
Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection, Ann Am Thorac Soc, vol.11, issue.10, pp.1640-50, 2014. ,
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial, Thorax, vol.65, issue.4, pp.286-91, 2010. ,
Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.14, issue.3, pp.361-69, 2015. ,
DOI : 10.1016/j.jcf.2014.12.007
URL : https://doi.org/10.1016/j.jcf.2014.12.007
Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings, Res Microbiol, vol.148, issue.5, pp.447-54, 1997. ,
DOI : 10.1016/s0923-2508(97)83875-2
Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis, Thorax, vol.69, issue.8, pp.740-785, 2014. ,
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients, Eur Respir J, vol.31, issue.4, pp.822-851, 2008. ,
Pseudomonas aeruginosa in CF and non-CF homes is found predominantly in drains, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.14, issue.3, pp.341-387, 2015. ,
Geographical Differences in First Acquisition of Pseudomonas aeruginosa in Cystic Fibrosis, Ann Am Thorac Soc, vol.10, issue.2, pp.108-122, 2013. ,
Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic, J Hosp Infect, vol.4, issue.1, pp.31-40, 1983. ,
Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.31, issue.6, pp.1331-1368, 2000. ,
Epidemiology of Pseudomonas aeruginosa in cystic fibrosis and the possible role of contamination by dental equipment, J Hosp Infect, vol.36, issue.2, pp.117-139, 1997. ,
Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis, J Hosp Infect, vol.9, issue.1, pp.11-21, 1987. ,
DOI : 10.1016/0195-6701(87)90089-2
Fine Particulate Matter Exposure and Initial Pseudomonas aeruginosa Acquisition in Cystic Fibrosis, Ann Am Thorac Soc, vol.12, issue.3, pp.385-91, 2015. ,
Proximity to blue spaces and risk of infection with Pseudomonas aeruginosa in cystic fibrosis: A case-control analysis, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.14, issue.6, pp.741-788, 2015. ,
Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.19, issue.11, pp.483-89, 2013. ,
Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study, PloS One, vol.6, issue.11, pp.277-84, 2011. ,
Differential geographical risk of initial Pseudomonas aeruginosa acquisition in young US children with cystic fibrosis, Am J Epidemiol, vol.179, issue.12, pp.1503-1516, 2014. ,
Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening, Pediatr Pulmonol, vol.35, issue.4, pp.257-62, 2003. ,
Risk factors for Pseudomonas aeruginosa colonization in cystic fibrosis patients, Pediatr Infect Dis J, vol.9, issue.7, pp.494-98, 1990. ,
Environmental allergies and respiratory morbidities in cystic fibrosis, Pediatr Pulmonol, vol.48, issue.9, pp.857-64, 2013. ,
Risk factors for age at initial Pseudomonas acquisition in the cystic fibrosis epic observational cohort, J Cyst Fibros Off J Eur Cyst Fibros Soc, vol.11, issue.5, pp.446-53, 2012. ,
Cat and dog exposure and respiratory morbidities in cystic fibrosis, J Pediatr, vol.165, issue.4, pp.830-865, 2014. ,
Heritability of respiratory infection with Pseudomonas aeruginosa in cystic fibrosis, J Pediatr, vol.161, issue.2, pp.290-95, 2012. ,
, Association française pour le dépistage et la prévention des handicaps de l'enfant. Organisation du programme de dépistage néonatal de la mucoviscidose, 2001.
Cystic fibrosis: terminology and diagnostic algorithms, Thorax, vol.61, issue.7, pp.627-662, 2006. ,
Bronchoscopy in cystic fibrosis infants diagnosed by newborn screening, Pediatr Pulmonol, vol.46, issue.7, pp.696-700, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00618191
Sensitivity and specificity of oropharyngeal suction versus bronchoalveolar lavage in identifying respiratory tract pathogens in children with chronic pulmonary infection, Pediatr Pulmonol, vol.20, issue.1, pp.40-43, 1995. ,
Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis, Pediatr Pulmonol, vol.28, issue.5, pp.321-349, 1999. ,
, Météo France Lorraine disponible sur www.meteofrance
The influence of air pollution during intrauterine development and early childhood on respiratory functions at later age, Int J Hyg Environ Health, vol.212, issue.5, pp.519-551, 2009. ,
Pediatric origins of adult lung disease. 1. The contribution of airway development to paediatric and adult lung disease, Thorax, vol.55, issue.7, pp.587-94, 2000. ,
Influence of air pollution on respiratory health during perinatal development, Clin Exp Pharmacol Physiol, vol.33, issue.3, pp.269-72, 2006. ,
Lifetime Exposure to Ambient Pollution and Lung Function in Children, Am J Respir Crit Care Med, vol.193, issue.8, pp.881-88, 2015. ,
Early-Life Exposure to Traffic-related Air Pollution and Lung Function in Adolescence, Am J Respir Crit Care Med, vol.193, issue.2, pp.171-77, 2016. ,
Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis, Am J Respir Crit Care Med, vol.169, issue.7, pp.816-837, 2004. ,
Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease, JAMA, vol.299, issue.4, pp.417-441, 2008. ,
Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis, Eur Respir J, vol.33, issue.2, pp.305-316, 2009. ,
Bronchopulmonary disease in children with cystic fibrosis after early or delayed diagnosis, Am J Respir Crit Care Med, vol.168, issue.9, pp.1100-1108, 2003. ,
Pseudomonas aeruginosa in children with cystic fibrosis diagnosed through newborn screening: assessment of clinic exposures and microbial genotypes, Pediatr Pulmonol, vol.45, issue.7, pp.708-724, 2010. ,
Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis, Glycobiology, vol.21, issue.3, pp.271-82, 2011. ,
Genetic modifiers of lung disease in cystic fibrosis, N Engl J Med, vol.353, issue.14, pp.1443-53, 2005. ,
Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis, J Pediatr, vol.155, issue.5, pp.634-673, 2009. ,
Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function, J Pediatr, vol.157, issue.5, pp.802-809, 2010. ,
Early antibiotic treatment for Pseudomonas aeruginosa eradication in patients with cystic fibrosis: a randomised multicentre study comparing two different protocols, Thorax, vol.67, issue.10, pp.853-59, 2012. ,
Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis, REGLEMENTATION CONCERNANT LA POLLUTION ? Valeurs recommandées selon l'OMS, vol.8, 2015. ,
DOI : 10.1002/14651858.cd001399.pub3
, Le droit français concernant la qualité de l'air est fondée sur la loi n°96-1236 du 30 décembre 1996 sur l'air et l'utilisation rationnelle de l'énergie (LAURE) condifiée dans le code de l'environnement. Cette loi s'appuie sur le "droit reconnu à chacun de respirer un air qui ne nuise pas à sa santé
, juillet 2010 portant engagement national pour l'environnement
, Code de l'Environnement version consolidée au 17 novembre 2014 : la loi LAURE a été intégrée au code de l'environnement Livre II Titre II ? Directives européennes
, Des directives européennes sont à l'origine de la réglementation française pour l'air ambiant, qui déterminent des seuils à ne pas dépasser pour une vingtaine de polluants en fonction de leur impact sur la santé humaine
, La réglementation européenne est basée sur les directives suivantes : Directive 2008/50/CE du Parlement Européen et du Conseil du 21 mai 2008 concernant la qualité de l'air ambiant et un air pur pour l'Europe